يعرض 1 - 20 نتائج من 7,641 نتيجة بحث عن '(( i marked decrease ) OR ((( a marked decrease ) OR ( a ((non decrease) OR (point decrease)) ))))', وقت الاستعلام: 0.72s تنقيح النتائج
  1. 1

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

    منشور في 2025
    "…<p>(A) Ki-67 expression in parathyroid glands of rats with CKD-induced sHPT treated with Cinacalcet either early in the inactive light phase (<i>Cina1</i>; N = 10) or early in the active dark phase (<i>Cina2</i>; N = 9) compared to untreated rats with sHPT investigated at similar time points (<i>PNX1</i>; N = 7 and <i>PNX2</i>; N = 7, respective) and to normal rats investigated at similar time points (<i>ctrl1</i>; N = 9 and <i>ctrl2</i>; N = 7, respective). …"
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    <sup>1</sup>H NMR spectra for kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  7. 7

    CCND1 is a target gene of miR-1247-3p. حسب Dequan Wang (6007007)

    منشور في 2024
    الموضوعات:
  8. 8

    The Laboratory Animal Flow Diagram. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  9. 9

    <sup>13</sup>C NMR spectra for Kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  10. 10

    The structures of T3 and Kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  11. 11

    Synthesis process of Kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  12. 12

    ESI-HRMS spectra for Kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  13. 13
  14. 14

    S1 File - حسب Hongyu Li (1332669)

    منشور في 2025
    "…Following the overexpression of miRNA 221 in myocardium, there was a marked alleviation of myocardial injury and cardiomyocyte apoptosis and necrosis, significant enhancement of left ventricular systolic function, and marked decrease in the levels of PLB, p-PLB (Ser16), p-PLB (Thr17), caspase 3 and Cyt C, as well as a significant decrease in total calcium levels in myocardium.…"
  15. 15
  16. 16
  17. 17
  18. 18

    Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

    منشور في 2025
    "…Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. …"
  19. 19
  20. 20